CNBC’s Angelica Peebles joins ‘Fast Money’ with breaking news on GSK and its drug Leucovorin.
Source link
Trending
- Big Tech delays India data center deals under weight of trade tensions
- Lights out and away we go into the new week
- Nikkei 225, Kospi, Nifty 50
- Bridgewater says investors are missing three big bets hiding beyond U.S. megacaps
- When it seems nothing can take the market down, follow this rule
- Stock market today: Live updates
- Trump’s tax changes for your charitable giving: What to know
- Good communicators ‘have a tolerance for discomfort’
GSK to submit label update for Leucovorin at FDA's request, does not intend to market it for autism
